Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-006154
Filing Date
2025-03-03
Accepted
2025-03-03 16:18:17
Documents
1
Period of Report
2025-02-28

Document Format Files

Seq Description Document Type Size
1 form4-03032025_090314.html 4  
1 form4-03032025_090314.xml 4 4089
  Complete submission text file 0001415889-25-006154.txt   5496
Mailing Address 5959 HORTON STREET SUITE 500 EMERYVILLE CA 94608
Business Address
Mitchell Shawnte (Reporting) CIK: 0001749432 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39712 | Film No.: 25698201

Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Issuer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)